DR MICHAEL BAKER – CHIEF EXECUTIVE OFFICER
Dr Baker was an Investment Manager with the leading Australian life science fund, BioScience Managers, where he was responsible for deal sourcing from networks, conferences, universities and research institutes. He also conducted due diligence to shortlist investment opportunities and played an active role in managing portfolio companies. Michael was a senior manager at Hexima Limited which specialises in developing agricultural and pharmaceutical products.
Dr Baker has a PhD in Biochemistry and was also awarded the prestigious Nancy Millis award for the most outstanding thesis for the Faculty of Science, Technology and Engineering, 2010. He was an Alexander von Humboldt Research Fellow at the University of Cologne with nine publications, one in the prestigious journal Science. He was also awarded an MBA at Melbourne Business School, where he was included in the Dean’s Honours List for being in the top 10% of graduating students.
DR CAROL WORTH – CHIEF TECHNICAL MANAGER
Dr. Worth has been working in the area of drug delivery systems for over 25 years at various international companies. As a development chemist, she liaised between companies in USA, UK and Asia to develop oral formulations of injectable peptide hormones. She has since been involved in the development of novel anticancer drugs and, most recently, topical pain relief formulations. Dr Worth has extensive experience in the setting up and running of GMP accredited laboratories and development of robust products suitable for GMP manufacturing. Dr. Worth has a PhD in Natural Product Chemistry from the University of Western Australia.
DR DEBORAH COOPER – PROJECT MANAGER
Dr Deborah Cooper is a Biotech professional with 25 years’ experience, expert in Cell Biology/Immunology, Clinical, Manufacturing, Product Development and Project Management. Deborah has 12 years in management of commercial technology organisations, including 7 years at the executive level. Deborah has worked for 4 years as an independent consultant to the Biotech sector, involved in managing product development, commercialisation strategy, regulatory submissions, grant applications, feasibility studies, GMP facilities, intellectual property management and placement of contract manufacturing, pre-clinical and clinical studies. Deborah has worked for 9 years in scientific research in private, not for profit and academic organisations; and 7 years studying at recognised tertiary institutions, achieving qualifications to the PhD level in the biological sciences arena.
JOSEPH OHAYON – CHIEF FINANCIAL OFFICER & COMPANY SECRETARY
Joseph Ohayon joined the company in July 2010 as the Chief Financial Officer and in March 2011 he took over the role of Company Secretary. He has over 30 years experience in financial roles including 18 years within health-related industries. Joseph qualified as a Chartered Accountant in the UK and graduated with a Masters of Business Administration in International Business from Murdoch University in 2007.